Your shopping cart is currently empty

D-Leucine ((R)-Leucine) potently terminates seizures even after the onset of seizure activity. D-leucine reduces long-term potentiation but had no effect on basal synaptic transmission in vitro.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 g | $31 | - | In Stock |
| Description | D-Leucine ((R)-Leucine) potently terminates seizures even after the onset of seizure activity. D-leucine reduces long-term potentiation but had no effect on basal synaptic transmission in vitro. |
| In vitro | D-Leucine failed to compete for binding by cognate ligands in a screen of candidate neuronal receptors, potentially suggesting a novel target. D-Leucine suppressed ongoing seizures at least as effectively as diazepam even at low doses, but without sedative effects. These studies raise the possibility that D-Leucine may represent a new class of anti-seizure agents, and that D-Leucine may have a previously unknown function in eukaryotes[1]. |
| Synonyms | (R)-Leucine |
| Molecular Weight | 131.17 |
| Formula | C6H13NO2 |
| Cas No. | 328-38-1 |
| Smiles | CC(C)C[C@@H](N)C(O)=O |
| Relative Density. | 1.035 g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO: < 1 mg/mL |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.